Tag: Randomized controlled trials

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial

May 15, 2026

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial

Obicetrapib for Heterozygous Familial Hypercholesterolemia: The BROOKLYN Trial

April 18, 2026

Obicetrapib for Heterozygous Familial Hypercholesterolemia: The BROOKLYN Trial

Elraglusib and Gemcitabine Plus Nab-Paclitaxel Improve Survival in Metastatic Pancreatic Cancer

April 14, 2026

Elraglusib and Gemcitabine Plus Nab-Paclitaxel Improve Survival in Metastatic Pancreatic Cancer

Gotistobart Improves Survival in Squamous NSCLC After Chemotherapy | Nature Medicine

March 27, 2026

Gotistobart Improves Survival in Squamous NSCLC After Chemotherapy | Nature Medicine

Competing Interests & Financial Disclosures

March 1, 2026

Competing Interests & Financial Disclosures

Web Analytics Made Easy - Statcounter